Live Feeds
● LIVE Updated 57m ago · 18 sources tracked

It Can Keep Cancer in Remission. Why Is No One Talking About It?

Cancer deaths are declining as survival rates rise due to improved early detection, prevention, and targeted therapies. Recent clinical evidence highlights the role of exercise in slowing biological aging for breast cancer survivors and benefiting patients generally. Additionally, the NEOPRISM-CRC trial demonstrates that a short course of pembrolizumab immunotherapy before surgery can prevent recurrence in some patients with stage two or three bowel cancer for nearly three years. These advancements reflect a shift toward personalized oncology based on genetic alterations and immune environments rather than just tumor location.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~3 min
Speed:
RSS Source map (18)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ Cancer deaths are falling while survival rates increase due to therapies, early detection, and prevention.
  • ✓ Exercise provides benefits for cancer patients and survivors, including the potential to slow biological aging after breast cancer.
  • ✓ Modern oncology is shifting toward personalized treatments based on genetic alterations, immune environments, and molecular subtypes.
🛡️ Source Corroboration: 18 independent reporting domains (85% confidence) ⏱ Read time: ~2 min

What changed

The NEOPRISM-CRC trial showed zero recurrences over three years for specific bowel cancer patients treated with pembrolizumab before surgery.

Live updates

  1. Exercise and Immunotherapy Drive Gains in Cancer Survival and Remission

    Cancer deaths are declining as survival rates rise due to improved early detection, prevention, and targeted therapies. Recent clinical evidence highlights the role of exercise in slowing biological aging for breast cancer survivors and benefiting patients generally. Additionally, the NEOPRISM-CRC trial demonstrates that a short course of pembrolizumab immunotherapy before surgery can prevent recurrence in some patients with stage two or three bowel cancer for nearly three years. These advancements reflect a shift toward personalized oncology based on genetic alterations and immune environments rather than just tumor location.

    Why it matters

    Medical oncology is moving toward precision care that considers molecular subtypes and protein expression. This shift aims to address persistent gaps in care despite overall survival gains. Research funding uncertainty remains a threat to future progress in these fields.

    What is confirmed

    • Cancer deaths are falling while survival rates increase due to therapies, early detection, and prevention.
    • Exercise provides benefits for cancer patients and survivors, including the potential to slow biological aging after breast cancer.
    • Modern oncology is shifting toward personalized treatments based on genetic alterations, immune environments, and molecular subtypes.

    Still unconfirmed

    • Innovative Medicine drove 7.9% growth for J&J with revenue hitting $25.4 billion.

    What to watch next

    • Results from the FAU research study involving breast cancer survivors.
    • Updates on research funding stability to sustain survival gains.
    • Long-term follow-up data from the NEOPRISM-CRC immunotherapy trial.
    Sources used for this update (18)
    1. www.nytimes.com — The New York Times - Breaking News, US News, World News and Videos
    2. www.dailymail.com — UK Home | Daily Mail Online
    3. The New York Times — It Can Keep Cancer in Remission. Why Is No One Talking About It?
    4. Bioengineer.org — Exercise May Slow Aging at the Cellular Level, and Genetics Helps Explain How
    5. The Palm Beach Post — Breast cancer survivors needed for FAU research study
    6. Cancer Nursing Today — Exercise May Slow Biological Aging After Breast Cancer
    7. Oncodaily — AACR Highlights the Benefits of Exercise for Cancer Patients and Survivors
    8. www.aol.com — J&J (JNJ) Q3 2026 Earnings Call Transcript - AOL
    9. www.targetedonc.com — AACR Report Highlights Gains in Cancer Survival and ...
    10. www.curetoday.com — Recovery Did Not End With Remission for a Leukemia Survivor
    11. www.yahoo.com — ‘The Challenge’s Justin Hinsley Talks Back-to-Back Heartbreaks
    12. www.sciencedaily.com — Bowel cancer “melted away” after immunotherapy, then stayed away
    confidence 85%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community